Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group

European Journal of Cancer and Clinical Oncology - Tập 21 - Trang 1321-1324 - 1985
A.J. Lacave1, J. Wils2, E. Diaz-Rubio3, M. Clavel4, A. Planting5, H. Bleiberg6, N. Duez7, O. Dalesio7
1Hospital General de Asturias, Oviedo, 33006, Spain
2Laurentius Hospital, Roermond, The Netherlands
3Hospital Clínico San Carlos, Madrid, Spain
4Centre León Bérard, Lyon, France
5Radiotherapeutic Institute, Rotterdam, The Netherlands
6Institut Jules Bordet, Brussels, Belgium
7EORTC Data Center, Brussels, Belgium

Tài liệu tham khảo

MacDonald, 1982, Cancer of the stomach, 534 Lacave, 1979, Methyl-CCNU (Me), 5-fluorouracil (F), adriamycin (A) (MeFA) versus MeF in advanced gastric cancer, 20, 310 MacDonald, 1980, 5-Fluorouracil, doxorubicin, mitomycin-C (FAM) combination chemotherapy for advanced gastric cancer, Ann Intern Med, 93, 535, 10.7326/0003-4819-93-4-533 The Gastrointestinal Tumor Study Group, 1979, Phase II–III chemotherapy studies in advanced gastric cancer, Cancer Treat Rep, 63, 1871 Douglas, 1984, An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin-C, adriamycin and 5-fluorouracil in advanced measurable gastric cancer (EST 2277), J Clin Oncol, 2, 1312 The Gastrointestinal Tumor Study Group, 1984, Randomized study of combination chemotherapy in unresectable gastric cancer, Cancer, 53, 13, 10.1002/1097-0142(19840101)53:1<13::AID-CNCR2820530104>3.0.CO;2-0 Heim, 1984, Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, adriamycin (doxorubicin) and mitomycin-C (modified FAM), Cancer, 54, 1999, 10.1002/1097-0142(19841101)54:9<1999::AID-CNCR2820540935>3.0.CO;2-E Lacave, 1985, A randomized trial of MeFA vs FA in advanced gastric cancer, 4, 78 Cullinan, 1984, A randomized comparison of 5-FU alone (F), 5-FU and adriamycin (FA), and 5-FU + adriamycin + mitomycin C (FAM) in gastric and pancreatic cancer, 3, 137 Loehrer, 1984, Cisplatin, Ann Intern Med, 100, 704, 10.7326/0003-4819-100-5-704 Izarzugaza, 1979, Phase II clinical study of CDDP in gastric cancer resistent to chemotherapy Lacave, 1983, Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer, Am J Clin Oncol, 6, 35, 10.1097/00000421-198302000-00005 1979 Beer, 1983, A phase II study of cisplatin in advanced gastric cancer, Eur J Cancer Clin Oncol, 19, 717, 10.1016/0277-5379(83)90003-2 Leichman, 1984, Cisplatin: an active drug in the treatment of disseminated gastric cancer, Cancer, 53, 18, 10.1002/1097-0142(19840101)53:1<18::AID-CNCR2820530105>3.0.CO;2-J Vogl, 1984, Cis-Platinum in refractory gastric cancer, 24, 147 Lee, 1981, Statistical contribution to phase II trials in cancer: interpretation, analysis and design, Semin Oncol, 8, 403 Woolley, 1981, A phase II trial of 5-FU, adriamycin and cisplatin (FAP) in advanced gastric cancer, 22, 455 Wagener, 1983, A phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer, 2, 115 Moertel, 1984, A phase II trial of combined intensive course 5-FU, adriamycin and cis-platinum in advanced gastric cancer and pancreatic carcinoma, 3, 137